Ali R. Ramezani, MD, Hamid Ahmadieh, MD Purpose: To evaluate the therapeutic effect of propranolol on central serous chorioretinopathy (CSCR). Methods: In a prospective interventional case series, 18 eyes with CSCR received 40 mg/day propranolol for 6 weeks. Complete ophthalmologic examination was performed before intervention and at 2 and 6 months. The outcome measures were retinal neurosensory detachment size, evaluated by paired t-test,...

Read More